NCT00055783View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2002

Study Completion Date

April 30, 2003

Conditions
Lymphoma
Interventions
BIOLOGICAL

apolizumab

Trial Locations (1)

94305-5408

Stanford University Medical Center, Stanford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT00055783 - Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter